Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
20
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Francois Eric | Director | 1 | $0 | $0 | 2026-03-04 |
| Pierce Kristen | Chief Development Officer | 3 | $0 | $0 | 2026-01-07 |
| KUCHARCHUK ANDREW ALBERT | Chief Financial Officer | 3 | $0 | $0 | 2026-01-07 |
| Rolfe Lindsey | Director | 6 | $0 | $0 | 2026-01-07 |
| Byrnes Michael | Director | 6 | $0 | $0 | 2026-01-07 |
| Patel Shami | Director | 5 | $0 | $0 | 2026-01-07 |
| Ehrlich Christopher B | Interim Chairman and CEO | 20 | $0 | $0 | 2026-01-07 |
| ATWOOD BRIAN G | Director | 27 | $0 | $0 | 2026-01-07 |
| LAPORTE KATHLEEN | Director | 11 | $0 | $0 | 2026-01-07 |
| YK Bioventures Opportunities GP I, LLC | 10% Owner | 3 | $0 | $400.5K | 2024-12-13 |
| Kossar Mitchell William | 10% Owner | 4 | $0 | $708.4K | 2024-12-10 |
| SLOAN STUART M | 10% Owner | 1 | $0 | $53.2K | 2024-09-25 |
| Carter Charles Ross | Chief Financial Officer | 2 | $0 | $0 | 2024-06-28 |
| Corey Daniel | Chief Technical Officer | 1 | $0 | $0 | 2024-03-25 |
| Rapaport Robyn | Director | 1 | $0 | $0 | 2024-03-25 |
| PHOENIX BIOTECH SPONSOR, LLC | 10% Owner | 6 | $0 | $0 | 2024-02-14 |
| Kosacz Barbara | Director | 1 | $0 | $0 | 2024-02-14 |
| Fisher Douglas Carl | President | 3 | $0 | $0 | 2024-02-14 |
| Loewy Caroline M | Director | 1 | $0 | $0 | 2024-02-14 |
| Geffken Daniel E. | Chief Financial Officer | 1 | $0 | $0 | 2024-02-14 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Francois Eric | Director | A Award deriv | 2026-03-04 | 2026-04-21 | 1,823,278 | — | $0 | 1,823,278 | SEC↗ |
| Pierce Kristen | Chief Development Officer | A Award deriv | 2026-01-07 | 2026-01-09 | 1,612,099 | — | $0 | 1,612,099 | SEC↗ |
| Patel Shami | Director | A Award deriv | 2026-01-07 | 2026-01-09 | 690,900 | — | $0 | 690,900 | SEC↗ |
| LAPORTE KATHLEEN | Director | A Award deriv | 2026-01-07 | 2026-01-09 | 690,900 | — | $0 | 690,900 | SEC↗ |
| KUCHARCHUK ANDREW ALBERT | Chief Financial Officer | A Award deriv | 2026-01-07 | 2026-01-09 | 1,162,099 | — | $0 | 1,162,099 | SEC↗ |
| Byrnes Michael | Director | A Award deriv | 2026-01-07 | 2026-01-09 | 690,900 | — | $0 | 690,900 | SEC↗ |
| Rolfe Lindsey | Director | A Award deriv | 2026-01-07 | 2026-01-09 | 690,900 | — | $0 | 690,900 | SEC↗ |
| ATWOOD BRIAN G | Director | A Award deriv | 2026-01-07 | 2026-01-09 | 1,612,099 | — | $0 | 1,612,099 | SEC↗ |
| Ehrlich Christopher B | Chairman and CEO | A Award deriv | 2026-01-07 | 2026-01-09 | 4,530,997 | — | $0 | 4,530,997 | SEC↗ |
| KUCHARCHUK ANDREW ALBERT | Chief Financial Officer | A Award deriv | 2025-05-30 | 2025-06-02 | 152,500 | — | $0 | 152,500 | SEC↗ |
| Pierce Kristen | Chief Development Officer | A Award deriv | 2025-05-30 | 2025-06-02 | 154,841 | — | $0 | 154,841 | SEC↗ |
| ATWOOD BRIAN G | Director | A Award deriv | 2025-05-30 | 2025-06-02 | 122,549 | — | $0 | 122,549 | SEC↗ |
| Ehrlich Christopher B | Chairman and CEO | A Award deriv | 2025-05-30 | 2025-06-02 | 61,843 | — | $0 | 61,842 | SEC↗ |
| Patel Shami | Director | A Award deriv | 2025-05-30 | 2025-06-02 | 11,693 | — | $0 | 11,693 | SEC↗ |
| Rolfe Lindsey | Director | A Award deriv | 2025-05-30 | 2025-06-02 | 9,326 | — | $0 | 9,326 | SEC↗ |
| Byrnes Michael | Director | A Award deriv | 2025-05-30 | 2025-06-02 | 9,326 | — | $0 | 9,326 | SEC↗ |
| LAPORTE KATHLEEN | Director | A Award deriv | 2025-05-30 | 2025-06-02 | 9,326 | — | $0 | 9,326 | SEC↗ |
| ATWOOD BRIAN G | Director | M Exercise deriv | 2025-03-31 | 2025-04-04 | 294,460 | — | $0 | 11,660 | SEC↗ |
| ATWOOD BRIAN G | Director | M Exercise | 2025-03-31 | 2025-04-04 | 294,460 | — | $0 | 490,534 | SEC↗ |
| Ehrlich Christopher B | Chairman and CEO | A Award deriv | 2025-03-04 | 2025-03-06 | 119,486 | — | $0 | 119,486 | SEC↗ |
| ATWOOD BRIAN G | Director | A Award deriv | 2025-03-04 | 2025-03-06 | 14,936 | — | $0 | 14,936 | SEC↗ |
| Patel Shami | Director | A Award deriv | 2025-03-04 | 2025-03-06 | 14,936 | — | $0 | 14,936 | SEC↗ |
| Byrnes Michael | Director | A Award deriv | 2025-03-04 | 2025-03-06 | 17,923 | — | $0 | 17,923 | SEC↗ |
| Rolfe Lindsey | Director | A Award deriv | 2025-03-04 | 2025-03-06 | 17,923 | — | $0 | 17,923 | SEC↗ |
| LAPORTE KATHLEEN | Director | A Award deriv | 2025-03-04 | 2025-03-06 | 17,923 | — | $0 | 17,923 | SEC↗ |
| ATWOOD BRIAN G | Director | A Award deriv | 2025-02-24 | 2025-02-26 | 254,000 | — | $0 | 508,000 | SEC↗ |
| Byrnes Michael | Director | A Award deriv | 2025-02-24 | 2025-02-26 | 127,500 | — | $0 | 255,000 | SEC↗ |
| Ehrlich Christopher B | Chairman and CEO | A Award deriv | 2025-02-24 | 2025-02-26 | 1,275,000 | — | $0 | 2,550,000 | SEC↗ |
| LAPORTE KATHLEEN | Director | A Award deriv | 2025-02-24 | 2025-02-26 | 127,500 | — | $0 | 255,000 | SEC↗ |
| Patel Shami | Director | A Award deriv | 2025-02-24 | 2025-02-26 | 127,500 | — | $0 | 255,000 | SEC↗ |
| Rolfe Lindsey | Director | A Award deriv | 2025-02-24 | 2025-02-26 | 127,500 | — | $0 | 255,000 | SEC↗ |
| ATWOOD BRIAN G | Director | A Award deriv | 2025-02-07 | 2025-02-07 | 204,080 | — | $0 | 204,080 | SEC↗ |
| ATWOOD BRIAN G | Director | A Award deriv | 2025-02-07 | 2025-02-07 | 306,120 | $1.96 | $600.0K | 306,120 | SEC↗ |
| ATWOOD BRIAN G | Director | A Award deriv | 2025-02-07 | 2025-02-07 | 204,080 | $1.96 | $400.0K | 204,080 | SEC↗ |
| ATWOOD BRIAN G | Director | A Award deriv | 2025-02-07 | 2025-02-07 | 306,120 | — | $0 | 306,120 | SEC↗ |
| YK Bioventures Opportunities G | 10% Owner | S Sale | 2024-12-13 | 2024-12-13 | 2,998,908 | $0.06 | $179.9K | 13,005,169 | SEC↗ |
| YK Bioventures Opportunities G | 10% Owner | S Sale | 2024-12-12 | 2024-12-13 | 1,614,541 | $0.07 | $113.0K | 16,004,077 | SEC↗ |
| YK Bioventures Opportunities G | 10% Owner | S Sale | 2024-12-11 | 2024-12-13 | 1,343,801 | $0.08 | $107.5K | 17,618,618 | SEC↗ |
| Kossar Mitchell William | 10% Owner | S Sale | 2024-12-10 | 2024-12-10 | 1,570,947 | $0.09 | $141.4K | 18,962,419 | SEC↗ |
| Kossar Mitchell William | 10% Owner | S Sale | 2024-12-09 | 2024-12-10 | 850,543 | $0.11 | $93.6K | 20,533,366 | SEC↗ |
| Kossar Mitchell William | 10% Owner | S Sale | 2024-12-06 | 2024-12-10 | 1,236,874 | $0.12 | $148.4K | 21,383,909 | SEC↗ |
| Patel Shami | Director | A Award deriv | 2024-12-02 | 2024-12-04 | 127,500 | — | $0 | 127,500 | SEC↗ |
| ATWOOD BRIAN G | Director | A Award deriv | 2024-12-02 | 2024-12-04 | 254,000 | — | $0 | 254,000 | SEC↗ |
| Byrnes Michael | Director | A Award deriv | 2024-12-02 | 2024-12-04 | 127,500 | — | $0 | 127,500 | SEC↗ |
| LAPORTE KATHLEEN | Director | A Award deriv | 2024-12-02 | 2024-12-04 | 127,500 | — | $0 | 127,500 | SEC↗ |
| Rolfe Lindsey | Director | A Award deriv | 2024-12-02 | 2024-12-04 | 127,500 | — | $0 | 127,500 | SEC↗ |
| Ehrlich Christopher B | Chairman and CEO | A Award deriv | 2024-12-02 | 2024-12-04 | 1,275,000 | — | $0 | 1,275,000 | SEC↗ |
| Kossar Mitchell William | 10% Owner | S Sale | 2024-10-10 | 2024-11-14 | 3,250,000 | $0.10 | $325.0K | 22,620,783 | SEC↗ |
| Pierce Kristen | Chief Development Officer | A Award deriv | 2024-10-01 | 2024-10-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| KUCHARCHUK ANDREW ALBERT | Chief Financial Officer | A Award deriv | 2024-10-01 | 2024-10-02 | 500,000 | — | $0 | 500,000 | SEC↗ |
| ATWOOD BRIAN G | Director | D To issuer deriv | 2024-09-30 | 2024-10-02 | 1,317,956 | — | $0 | 0 | SEC↗ |
| ATWOOD BRIAN G | Director | D To issuer deriv | 2024-09-30 | 2024-10-02 | 13,857 | — | $0 | 0 | SEC↗ |
| Ehrlich Christopher B | Interim Chairman and CEO | D To issuer deriv | 2024-09-30 | 2024-10-02 | 572,182 | — | $0 | 0 | SEC↗ |
| ATWOOD BRIAN G | Director | M Exercise deriv | 2024-09-25 | 2024-10-02 | 1,002 | $1000.00 | $1.00M | 0 | SEC↗ |
| Ehrlich Christopher B | Interim Chairman and CEO | M Exercise deriv | 2024-09-25 | 2024-10-02 | 275 | $1000.00 | $275.0K | 0 | SEC↗ |
| LAPORTE KATHLEEN | Director | M Exercise deriv | 2024-09-25 | 2024-10-02 | 50 | $1000.00 | $50.0K | 0 | SEC↗ |
| ATWOOD BRIAN G | Director | M Exercise | 2024-09-25 | 2024-10-02 | 19,358,578 | — | $0 | 19,607,313 | SEC↗ |
| Ehrlich Christopher B | Interim Chairman and CEO | M Exercise | 2024-09-25 | 2024-10-02 | 5,312,983 | — | $0 | 5,791,808 | SEC↗ |
| LAPORTE KATHLEEN | Director | M Exercise | 2024-09-25 | 2024-10-02 | 965,997 | — | $0 | 965,997 | SEC↗ |
| SLOAN STUART M | 10% Owner | S Sale | 2024-09-25 | 2024-11-20 | 532,486 | $0.10 | $53.2K | 21,067,956 | SEC↗ |
| Carter Charles Ross | Chief Financial Officer | A Award deriv | 2024-06-28 | 2024-07-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ATWOOD BRIAN G | Chief Executive Officer | A Award deriv | 2024-03-25 | 2024-03-27 | 1,317,956 | — | $0 | 1,317,956 | SEC↗ |
| Byrnes Michael | Director | A Award deriv | 2024-03-25 | 2024-03-27 | 112,500 | — | $0 | 112,500 | SEC↗ |
| Carter Charles Ross | Chief Financial Officer | A Award deriv | 2024-03-25 | 2024-03-27 | 395,387 | — | $0 | 395,387 | SEC↗ |
| Corey Daniel | Chief Technical Officer | A Award deriv | 2024-03-25 | 2024-03-27 | 856,671 | — | $0 | 856,671 | SEC↗ |
| Ehrlich Christopher B | Director | A Award deriv | 2024-03-25 | 2024-03-27 | 572,182 | — | $0 | 572,182 | SEC↗ |
| LAPORTE KATHLEEN | Director | A Award deriv | 2024-03-25 | 2024-03-27 | 112,500 | — | $0 | 112,500 | SEC↗ |
| Rapaport Robyn | Director | A Award deriv | 2024-03-25 | 2024-03-27 | 112,500 | — | $0 | 112,500 | SEC↗ |
| Rolfe Lindsey | Director | A Award deriv | 2024-03-25 | 2024-03-27 | 112,500 | — | $0 | 112,500 | SEC↗ |
| ATWOOD BRIAN G | Chief Executive Officer | A Award deriv | 2024-02-14 | 2024-02-16 | 1,002 | $1000.00 | $1.00M | 1,002 | SEC↗ |
| Ehrlich Christopher B | Director | A Award deriv | 2024-02-14 | 2024-02-16 | 100 | $1000.00 | $100.0K | 100 | SEC↗ |
| Ehrlich Christopher B | Director | M Exercise deriv | 2024-02-14 | 2024-02-16 | 0 | — | $0 | 0 | SEC↗ |
| Ehrlich Christopher B | Director | M Exercise deriv | 2024-02-14 | 2024-02-16 | 1,555 | $1000.00 | $1.55M | 1,555 | SEC↗ |
| Ehrlich Christopher B | Director | J Other deriv | 2024-02-14 | 2024-02-16 | 1,555 | $1000.00 | $1.55M | 0 | SEC↗ |
| Ehrlich Christopher B | Director | J Other deriv | 2024-02-14 | 2024-02-16 | 175 | $1000.00 | $175.0K | 275 | SEC↗ |
| Ehrlich Christopher B | Director | J Other deriv | 2024-02-14 | 2024-02-16 | 349,998 | — | $0 | 0 | SEC↗ |
| Ehrlich Christopher B | Director | J Other deriv | 2024-02-14 | 2024-02-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| LAPORTE KATHLEEN | Director | A Award deriv | 2024-02-14 | 2024-02-16 | 50 | $1000.00 | $50.0K | 50 | SEC↗ |
| PHOENIX BIOTECH SPONSOR, LLC | 10% Owner | J Other deriv | 2024-02-14 | 2024-02-16 | 1,555 | $1000.00 | $1.55M | 0 | SEC↗ |
| PHOENIX BIOTECH SPONSOR, LLC | 10% Owner | J Other deriv | 2024-02-14 | 2024-02-16 | 349,998 | — | $0 | 0 | SEC↗ |
| PHOENIX BIOTECH SPONSOR, LLC | 10% Owner | M Exercise deriv | 2024-02-14 | 2024-02-16 | 1,555 | $1000.00 | $1.55M | 1,555 | SEC↗ |
| PHOENIX BIOTECH SPONSOR, LLC | 10% Owner | M Exercise deriv | 2024-02-14 | 2024-02-16 | 0 | — | $0 | 0 | SEC↗ |
| Fisher Douglas Carl | President | J Other deriv | 2024-02-14 | 2024-02-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Fisher Douglas Carl | President | A Award deriv | 2024-02-14 | 2024-02-16 | 50 | $1000.00 | $50.0K | 50 | SEC↗ |
| ATWOOD BRIAN G | Chief Executive Officer | A Award deriv | 2024-02-14 | 2024-02-21 | 1,002 | $1000.00 | $1.00M | 1,002 | SEC↗ |
| LAPORTE KATHLEEN | Director | A Award deriv | 2024-02-14 | 2024-02-21 | 50 | $1000.00 | $50.0K | 50 | SEC↗ |
| ATWOOD BRIAN G | Chief Executive Officer | A Award deriv | 2024-02-14 | 2024-03-11 | 1,002 | $1000.00 | $1.00M | 1,002 | SEC↗ |
| ATWOOD BRIAN G | Chief Executive Officer | A Award deriv | 2024-02-14 | 2024-03-11 | 13,857 | — | $0 | 13,857 | SEC↗ |
| ATWOOD BRIAN G | Chief Executive Officer | J Other | 2024-02-14 | 2024-02-16 | 148,208 | — | $0 | 248,735 | SEC↗ |
| ATWOOD BRIAN G | Chief Executive Officer | J Other | 2024-02-14 | 2024-02-16 | 100,527 | — | $0 | 100,527 | SEC↗ |
| ATWOOD BRIAN G | Chief Executive Officer | J Other | 2024-02-14 | 2024-02-16 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Ehrlich Christopher B | Director | J Other | 2024-02-14 | 2024-02-16 | 3,600 | — | $0 | 3,600 | SEC↗ |
| Ehrlich Christopher B | Director | J Other | 2024-02-14 | 2024-02-16 | 478,825 | — | $0 | 478,825 | SEC↗ |
| Ehrlich Christopher B | Director | J Other | 2024-02-14 | 2024-02-16 | 4,171,246 | — | $0 | 1,000,000 | SEC↗ |
| Ehrlich Christopher B | Director | J Other | 2024-02-14 | 2024-02-16 | 1,125,000 | — | $0 | 4,171,246 | SEC↗ |
| LAPORTE KATHLEEN | Director | J Other | 2024-02-14 | 2024-02-16 | 5,828 | — | $0 | 5,828 | SEC↗ |
| PHOENIX BIOTECH SPONSOR, LLC | 10% Owner | J Other | 2024-02-14 | 2024-02-16 | 4,171,246 | — | $0 | 1,000,000 | SEC↗ |
| PHOENIX BIOTECH SPONSOR, LLC | 10% Owner | J Other | 2024-02-14 | 2024-02-16 | 1,125,000 | — | $0 | 4,171,246 | SEC↗ |
| Fisher Douglas Carl | President | J Other | 2024-02-14 | 2024-02-16 | 43,300 | — | $0 | 43,300 | SEC↗ |
| Geffken Daniel E. | Chief Financial Officer | J Other | 2024-02-14 | 2024-02-16 | 10,002 | — | $0 | 10,002 | SEC↗ |
| Kosacz Barbara | Director | J Other | 2024-02-14 | 2024-02-16 | 5,828 | — | $0 | 5,828 | SEC↗ |
| Loewy Caroline M | Director | J Other | 2024-02-14 | 2024-02-16 | 5,828 | — | $0 | 5,828 | SEC↗ |
| ATWOOD BRIAN G | Chief Executive Officer | J Other | 2024-02-14 | 2024-02-21 | 148,208 | — | $0 | 248,735 | SEC↗ |
| ATWOOD BRIAN G | Chief Executive Officer | J Other | 2024-02-14 | 2024-02-21 | 100,527 | — | $0 | 100,527 | SEC↗ |
| ATWOOD BRIAN G | Chief Executive Officer | J Other | 2024-02-14 | 2024-03-11 | 148,208 | — | $0 | 248,735 | SEC↗ |
| ATWOOD BRIAN G | Chief Executive Officer | J Other | 2024-02-14 | 2024-03-11 | 100,527 | — | $0 | 100,527 | SEC↗ |